This revised textbook examines the most important aspects of multiple sclerosis that impact on clinical trial design, on the development of new disease therapies, and, very importantly, on patient care. The international team of contrib4tors discusses the clinical course of multiple sclerosis, its clinical heterogeneity, and the presence of subclinical disease activity that occurs during the early stages of the disease. There have been substantial...